Stocks To Buy Now

Blog

The Stocks To Buy Now Blog

Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.

If you’re looking for market insight, undervalued gems, and an assortment of investment options, read on.

International Stem Cell Corp. (ISCOD) Preparing to Initiate Clinical Development for the Treatment of Parkinson’s Disease in Australia

International Stem Cell Corp. recently took a significant step toward expanding its clinical pipeline when it submitted preclinical data to the Australian Therapeutic Goods Administration (TGA) regarding its impending phase I/IIa clinical trial for the treatment of Parkinson’s disease. According to the submitted data, the company’s nine month study of 300 rodents resulted in no […]

Wisdom Homes of America, Inc. (WOFA) Experiences Faster Turn Cycles and Higher Revenue Transactions as Land/Home Buyers Increase

Wisdom Homes of America, an owner and operator of manufactured homes retail centers, has positioned itself to provide homebuyers the opportunity to purchase quality, affordable manufactured homes. “We previously stated that our goal was to expand into land/home transactions, which is exactly what we’ve done. We’re now closing land/home transactions, and our 90 day pipeline […]

On The Move Systems Corp. (OMVS): Survey Shows Shared Economy Platform Triggering Uber-style Trucking Platform

On the Move Systems this morning highlighted a new industry forecast that the trucking industry will soon experience an Uber-style transformation, where shared economy platforms and apps, like the one now under development by OMVS, will play an integral component of operations and revenue-generation. The Frost & Sullivan report predicts that by 2025 such platforms […]

Great Basin Scientific, Inc. (GBSN) Building Presence in Molecular Diagnostics Market through Commercialization of Cost-Effective Technologies

Great Basin Scientific is a molecular diagnostics company developing, manufacturing and commercializing breakthrough chip-based technologies that enable cost-effective, reliable infectious disease testing. By focusing on affordability and ease-of-use, the company is working to make molecular testing available to every patient, providing the means for greatly reduced misdiagnoses while significantly limiting the spread of dangerous infectious […]

Why Aquinox Pharmaceuticals (AQXP) Should be on Every Investor’s Radar

Canadian biotech Aquinox Pharmaceuticals (NASDAQ: AQXP) created quite the industry buzz last week when the company reported positive mid-stage trial results for its bladder pain drug, AQX-1125. In addition to meeting secondary endpoints, the LEADERSHIP trial also demonstrated that a high proportion of patients (49%) achieved a clinically meaningful improvement in pain (2 points or […]

Palatin Technologies, Inc. (PTN) Developing Novel Treatment for Condition that Affects 40 Percent of the Female Population

Palatin Technologies, Inc. (NYSE MKT: PTN) is a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with significant unmet medical need. The company’s leading product candidate, Bremelanotide, is currently set to begin two phase III clinical trials for the treatment of female sexual dysfunction (FSD). Additionally, Palatin’s development pipeline features a […]

 

From Our Blog

Strawberry Fields REIT, Inc. (NYSE AMERICAN: STRW) From Humble Beginnings to $18.4 Million Q2 2025 AFFO; Set to Announce Q3 Financial Results on November 6

October 30, 2025

Strawberry Fields REIT (NYSE: AMERICAN: STRW) (the “Company”), a self-administered real estate investment trust engaged in the ownership, acquisition, and leasing of skilled nursing and specific other healthcare-related properties, posted $18.4 million in Adjusted Funds From Operations (“AFFO”) for Q2 2025, a significant growth from $14.3 million during the same period in 2024. While announcing […]

Rotate your device 90° to view site.